Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of the 5-SENSE Score to Predict Focality of the Seizure-onset Zone as Assessed by Stereo-electroencephalography - a Prospective Multicenter Validation Study

NCT06138808 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT06138808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06138808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of the 5-SENSE Score to Predict Focality of the Seizure-onset Zone as Assessed by Stereo-electroencephalography - a Prospective Multicenter Validation Study
Lead sponsor
Duke University
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 9, 2024
Completion date
June 30, 2027
Enrollment
400 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy intractable